Live Breaking News & Updates on Methodological Standards

Stay updated with breaking news from Methodological standards. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Patients on ACE inhibitors, ARBs, don't have higher COVID-19 risk, fFnds study


 E-Mail
NEW YORK, NY (Dec. 17, 2020) While the COVID-19 pandemic left the world searching for answers during the earliest stages of the pandemic, one immediate healthcare concern regarded the use of certain antihypertensives and whether they posed increased risks to patients with hypertension.
A new study by global collaborators within the Observational Health Data Sciences and Informatics (OHDSI) community found that there was no increased risk of COVID-19 diagnosis, hospitalization, or subsequent complications for users of either angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) among an international cohort of more than 1.1 million patients using antihypertensives.
The study was published today in ....

United States , Marca Suchard , George Hripcsak , Daniel Morales , Spain Columbia University Irving Medical Center , European Network Of Centres , Information System For Research , Columbia University , Department Of Veteran Affairs , Columbia University Department Of Biomedical Informatics , Wellcome Trust Clinical Research , Lancet Digital Health , European Medicines Agency , Observational Health Data Sciences , University Of Dundee , Lancet Digital , Columbia University Irving Medical Center , Veteran Affairs , Information System , Primary Care , European Network , Methodological Standards , Wellcome Trust Clinical Research Fellow , Inhibition Utilization , Columbia University Department , Biomedical Informatics ,